Does ovarian stimulation increase the risk of ovarian cancer?

Reproductive Medicine Review

Volumn 11, Issue 1, 2003, Pages 57-66

  Dos Santos Silva, I ^a   Maclean, A B ^b   Mayer, D ^a,b   Hardiman, P J ^b   Lieberman, G ^b   Nieto, J J ^b   Parsons, M ^b   Rolfe, K ^b   Ginsburg, J ^c  

^a LONDON SCHOOL OF HYGIENE AND TROPICAL MEDICINE   (United Kingdom)

^b ROYAL FREE AND UNIVERSITY COLLEGE MEDICAL SCHOOL   (United Kingdom)

^c ROYAL FREE HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CHORIONIC GONADOTROPIN;

ADULT; AGED; CANCER INCIDENCE; CANCER RESEARCH; CANCER RISK; FEMALE; FOLLOW UP; GERM CELL TUMOR; GYNECOLOGIC CANCER; HORMONAL REGULATION; HUMAN; INFERTILITY; MAJOR CLINICAL STUDY; OVARY CANCER; OVULATION INDUCTION; PRIORITY JOURNAL; PROGNOSIS; REVIEW; RISK FACTOR;

EID: 4143144383     PISSN: 09622799     EISSN: None     Source Type: Journal    
DOI: 10.1017/S0962279903001017     Document Type: Review

References (48)

1. Swerdlow AJ, dos Santos Silva I, Doll R. Cancer Incidence and Mortality in England and Wales. Trends and Risk Factors. Oxford: Oxford University Press; 2001.
2. Cancer Research Campaign. Fact sheet 1.1, 1998.
3. dos Santos Silva I, Swerdlow AJ. Recent trends in incidence of and mortality from breast, ovarian and endometrial cancers in England and Wales and their relation to changing fertility and oral contraceptive use. Br J Cancer 1995; 72: 485-92.
4. Coleman MP, Babb P, Damiecki P et al. Cancer Survival Trends in England and Wales 1971-95 [Studies in Medical and Population Subjects no. 61]. London: The Stationery Office; 1999.
5. Weiss NS, Cook LS, Farrow DC, Rosenblatt KA. Ovarian cancer. In Schottenfeld D, Fraumeni JF Jr. (eds). Cancer Epidemiology and Prevention, second edition. Oxford: Oxford University Press; 1996: 1040-57.
6. Banks E, Beral V, Reeves G. The epidemiology of ovarian cancer: a review. Int J Gynecol Cancer 1997; 7: 425-38.
7. Herrinton LJ, Stanford JL, Schwartz SM, Weiss NS. Ovarian cancer incidence among Asian migrants to the United States and their descendents. J Natl Cancer Inst 1994; 86: 1336-9.
8. Cramer DW, Harlow BL, Willett WC et al. Galactose consumption and metabolism in relation to the risk of ovarian cancer. Lancet 1989; 2: 66-71.
9. Day NE, Boice JD (eds) (1983) Second Cancer in Relation to Radiation Treatment for Cervical Cancer [IARC Scientific Publications no. 52]. Lyon: IARC.
10. Harlow BL, Cramer DW, Bell DA, Welch WR. Perineal exposure to talc and ovarian cancer risk. Obstet Gynecol 1992; 80: 19-26.
11. Cramer DW, Hutchinson GB, Welch WR, Scully RE, Ryan KJ. Determinants of ovarian cancer risk. I. Reproductive experiences and family history. J Natl Cancer Inst 1983; 71: 711-16.
12. Kvale G, Heuch I, Nilssen S, Beral V. Reproductive factors and risk of ovarian cancer: A prospective study. Int J Cancer 1988; 42: 246-51.
13. Adami HO, Hsieh CC, Lambe M et al. Parity, age at first childbirth, and risk of ovarian cancer. Lancet 1994; 344: 1250-4.
14. Booth M, Beral V, Smith P. Risk factors for ovarian cancer: a case-control study. Br J Cancer 1989; 60: 592-8.
15. Whittemore AS, Harris R, Itnyre J et al. Characteristics relating to ovarian cancer risk: collaborative analysis of 12 US case-control studies. II. Invasive epithelial ovarian cancers in white women. Am J Epidemiol 1992; 136: 1184-203.
16. Cancer and Steroid Hormone Study of the Centers for Disease Control and the National Institute of Child Health and Human Development. The reduction in risk of ovarian cancer associated with oral-contraceptive use. N Engl J Med 1987; 316: 650-5.
17. Franceschi S, Parazzini F, Negri E et al. Pooled analysis of 3 European case-control studies of epithelial ovarian cancer: III. Oral contraceptive use. Int J Cancer 1991; 49: 61-5.
18. Narod SA, Risch H, Moslehi R et al. Oral contraceptives and the risk of hereditary ovarian cancer. N Engl J Med 1998; 339: 424-8.
19. Sanderson M, Williams MA, Weiss NS, Hendrix NW, Chauhan SP. Oral contraceptives and epithelial ovarian cancer. J Reprod Med 2000; 45: 720-6.
20. Irwin KL, Weiss NS, Lee NC, Peterson HB. Tubal sterilization, hysterectomy, and the subsequent occurrence of epithelial ovarian cancer. Am J Epidemiol 1991; 134: 362-9.
21. Sightler SE, Boike GM, Estape RE, Averette HE. Ovarian cancer in women with prior hysterectomy: a 14-years experience at the University of Miami. J Obstet Gynaecol 1991; 78: 681-4.
22. Parazzini F, Negri E, La Vecchia et al. Hysterectomy, oophorectomy, and subsequent ovarian cancer risk. Obstet Gynecol 1993; 81: 363-6.
23. Whittemore AS, Harris R, Itnyre J et al. Characteristics relating to ovarian cancer risk: collaborative analysis of 12 US case-control studies. IV. Pathogenesis of epithelial ovarian cancer. Am J Epidemiol 1992; 136: 1212-20.
24. Fathalla MF. Incessant ovulation. Lancet 1971; 2: 163.
25. Fathalla MF. Factors in the causation and incidence of ovarian cancer. Obstet Gynecol Survey 1972; 27: 751-68.
26. Cruickshank DJ. Aetiological importance of ovulation in epithelial ovarian cancer: a population based study. Br Med J 1990; 301: 524-5.
27. Potashnik G, Insler V, Meizner I, Sternberg M. Frequency, sequence, and side of ovulation in women menstruating normally. Br Med J 1987; 294: 219.
28. Scott JS. How to induce ovarian cancer: and how not to. Br Med J 1984; 289: 781-2.
29. Stadl BV. The etiology and prevention of ovarian cancer. Am J Obstet Gynecol 1975; 123: 772-4.
30. Helzlsouer KJ, Alberg AJ, Gordon GB et al. Serum gonadotrophins and steroid hormones and the development of ovarian cancer. J Am Med Assoc 1995; 274: 1926-30.
31. Whittemore AS, Harris R, Itnyre J et al. Characteristics relating to ovarian cancer risk. Collaborative analysis of 12 US case-control studies. III. Epithelial tumours of low malignant potential in white women. Am J Epidemiol 1992; 136: 1204-11.
32. Fishel S, Jackson P. Follicular stimulation for high tech pregnancies: are we playing it safe? Br Med J 1989; 299: 309-11.
33. Bamford PN, Steele SJ. Uterine and ovarian carcinoma in a patient receiving gonadotrophin therapy. Case report. Br J Obstet Gynaecol 1982; 89: 962-4.
34. Land JA. Ovulation, ovulation induction and ovarian carcinoma. Balliere's Clin Obstet Gynaecol 1993; 7: 455-72.
35. Hull M, Kriner M, Schneider E, Maiman M. Ovarian cancer after successful ovulation induction. A case report. J Reprod Med 1996; 41: 52-4.
36. Unkila-Kallio L, Leminen A, Tiitinen A, Lehtovirta P, Wahlstrom T, Ylikorkala O. Malignant tumours of the ovary or the breast in association with infertility. Acta Obstet Gynecol Scand 1997; 76: 177-81.
37. Ron E, Lunenfeld B, Menczer J et al. Cancer incidence in a cohort of infertile women. Am J Epidemiol 1987; 125: 780-90.
38. Modan B, Ron E, Lerner-Geva L et al. Cancer incidence in a cohort of infertile women. Am J Epidemiol 1998; 147: 1038-42.
39. Brinton LA, Melton J, Malkasian GD, Bond A, Hoover R. Cancer risk after evaluation for infertility. Am J Epidemiol 1989; 129: 712-22.
40. King TM. Ovarian cancer and fertility drugs. Cancer Bull 1994; 64: 181-4.
41. Shoham Z. Epidemiology, aetiology, and fertility drugs in ovarian epithelial carcinoma: Where are we today? Fertil Steril 1994; 62: 433-48.
42. Rossing MA. Ovarian cancer: a risk of infertility treatment? J Br Fertil Soc 1996; 1: 46-50.
43. Rossing MA, Daling JR, Weiss NS, Moore DE, Self SE. Ovarian tumours in a cohort of infertile women. N Engl J Med 1994; 331: 771-6.
44. Sushan A, Paltiel O, Iscovich J, Elchalal U, Peretz T, Schenker JG. Human menopausal gonadotrophins and the risk of epithelial ovarian cancer. Fertil Steril 1996; 65: 13-18.
45. Ness RB, Cramer DW, Goodman MT et al. Infertility, fertility drugs, and ovarian cancer: a pooled analysis of case-control studies. Am J Epidemiol 2002; 155: 217-24.
46. Venn A, Watson L, Lumley J, Giles G, King C, Healy D. Breast and ovarian cancer incidence after infertility and in vitro fertilisation. Lancet 1995; 346: 995-1000.
47. Venn A, Watson L, Bruinsma F, Giles G, Healy D. Risk of cancer after use of fertility drugs with in-vitro fertilisation. Lancet 1999; 354: 1586-90.
48. Klip H, Burger CW, Kenemans P, van Leeuwen FE. Cancer risk associated with subfertility and ovulation induction: a review. Cancer Causes Control 2000; 11: 319-44.